0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Is Universal Neonatal Hemoglobinopathy Screening Cost-effective?

Abraham B. Bergman, MD
Arch Pediatr Adolesc Med. 1995;149(4):466. doi:10.1001/archpedi.1995.02170160120022.
Text Size: A A A
Published online

The article by Sprinkle et al1 published in the May issue of the Archives is an example of how the "science" of economics can be employed to justify most any conclusion. Costs and benefits depend on what factors are laid on the scale. In this case, some of the important ingredients were left on the shelf.

The authors criticize other work that focuses solely on the decreased risk of pneumococcal sepsis in infants receiving prophylactic penicillin after the diagnosis of sickle-cell disease (SCD) was made. They say, [This approach] does not account for a range of other unambiguously valuable effects. The early diagnosis of non-SCD conditions such as sickle trait, nonsickle hemoglobinopathies, and some thalassemias allows the timely provision of genetic, medical, and social-services counseling."

A valid cost-benefit analysis would attempt to factor in the extent of harm inflicted on the huge number of infants with false-positive results, as

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();